Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:21 - 50
Updated:1/13/2017
Start Date:August 2011
End Date:June 2012

Use our guide to learn which trials are right for you!

Phase 1 Study of Interactions Between Oral Naltrexone and Bupropion and Intravenous Methamphetamine in Methamphetamine Experienced Volunteers

The study is to primarily measure safety and interactions between oral doses of
Naltrexone/Bupropion and i.v. Methamphetamine.


Inclusion Criteria:

- Are MA experienced but not dependent, males or females aged 21-to-50 years.

- Reported use of MA during the past six months without experiencing an adverse
consequence plus a life time MA or amphetamine use history of at least four occasions
of use.

- Have a body mass index (BMI) between 18 and 30.

- Are willing and able to give written consent.

- Are not currently a subject (including still in the follow-up period) of another drug
research study.

- Have no medical contraindications determined by the following: an adequate medical
history, a physical examination including vital signs, 12-lead ECG, hematology, blood
chemistry, and urinalysis.

- Have a negative drug test for barbiturates, benzodiazepines, opiates, cocaine,
amphetamines and ethanol at the time of hospital admission (Day 0).

- Are females who have a negative pregnancy test at hospital admission.

- Are of either non-childbearing (tubal ligation or total hysterectomy) or of
childbearing potential using one or more of the following barrier methods of
contraception: male or female condoms (with/without spermicide), diaphragm (with
spermicide) and/or copper containing intrauterine device (with/without spermicide).
No other contraceptives are acceptable.

Exclusion Criteria:

- Please contact site for more information
We found this trial at
1
site
San Francisco, California 94143
?
mi
from
San Francisco, CA
Click here to add this to my saved trials